本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Zenas BioPharma Inc.

21.84
+0.32501.51%
盘后22.480.6400+2.93%19:48 EDT
成交量:20.33万
成交额:440.74万
市值:9.20亿
市盈率:-4.11
高:22.21
开:21.68
低:21.34
收:21.52
52周最高:26.25
52周最低:5.83
股本:4,211.03万
流通股本:2,107.19万
量比:0.58
换手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):-5.3099
每股收益(LYR):-11.8940
净资产收益率:-88.40%
总资产收益率:-47.94%
市净率:3.84
市盈率(LYR):-1.84

数据加载中...

2025/09/02

重要事件披露

Form 8-K - Current report
2025/08/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/12

重要事件披露

Form 8-K - Current report
2025/06/13

重要事件披露

Form 8-K - Current report
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/15

重要事件披露

Form 8-K - Current report
2025/03/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/05

重要事件披露

Form 8-K - Current report
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/21

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/25

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans